Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1
Authors:
- Lucie BarateauLBLucie Barateau
- Isabelle JaussentIJIsabelle Jaussent
- Stefano VandiSVStefano Vandi
- Elena AntelmiEAElena Antelmi
- Yves DauvilliersYves Dauvilliers
- Giuseppe PlazziGiuseppe Plazzi
- for the MonBo Study GroupFGfor the MonBo Study Group
- 10 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 93 (11) , E1034-E1044
Abstract
To validate polysomnographic markers (sleep latency and sleep-onset REM periods [SOREMPs] at the Multiple Sleep Latency Test [MSLT] and nocturnal polysomnography [PSG]) for pediatric narcolepsy type 1 (NT1) against CSF hypocretin-1 (hcrt-1) deficiency and presence of cataplexy, as no criteria are currently validated in children. Clinical, neurophysiologic, and, when available, biological data (HLA-DQB1*06:02 positivity, CSF hcrt-1 levels) of 357 consecutive children below 18 years of age evaluated for suspected narcolepsy were collected. Best MSLT cutoffs were obtained by receiver operating characteristic (ROC) curve analysis by contrasting among patients with available CSF hcrt-1 assay (n = 228) with vs without CSF hcrt-1 deficiency, and further validated in patients without available CSF hcrt-1 against cataplexy (n = 129). Patients with CSF hcrt-1 deficiency were best recognized using a mean MSLT sleep latency ≤8.2 minutes (area under the ROC curve of 0.985), or by at least 2 SOREMPs at the MSLT (area under the ROC curve of 0.975), or the combined PSG + MSLT (area under the ROC curve of 0.977). Although specificity and sensitivity of reference MSLT sleep latency ≤8 minutes and ≥2 SOREMPs (nocturnal SOREMP included) was 100% and 94.87%, the combination of MSLT sleep latency and SOREMP counts did not improve diagnostic accuracy. Age or sex also did not significantly influence these results in our pediatric population. At least 2 SOREMPs or a mean sleep latency ≤8.2 minutes at the MSLT are valid and reliable markers for pediatric NT1 diagnosis, a result contrasting with adult NT1 criteria. This study provides Class III evidence that for children with suspected narcolepsy, polysomnographic and MSLT markers accurately identify those with narcolepsy type 1.Keywords
This publication has 47 references indexed in Scilit:
- Test-Retest Reliability of the Multiple Sleep Latency Test in Narcolepsy without Cataplexy and Idiopathic HypersomniaJournal of Clinical Sleep Medicine, 2013
- Clinical, polysomnographic and genome‐wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network studyJournal of Sleep Research, 2013
- Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentationVaccine, 2013
- Predictors of Hypocretin (Orexin) Deficiency in Narcolepsy Without CataplexySLEEP, 2012
- Complex movement disorders at disease onset in childhood narcolepsy with cataplexyBrain, 2011
- Cataplexy features in childhood narcolepsyMovement Disorders, 2008
- Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adultsBrain, 2006
- Narcolepsy in prepubertal childrenAnnals of Neurology, 1998
- Narcolepsy.Archives of Disease in Childhood, 1992
- Narcolepsy in childhood and adolescenceArquivos de Neuro-Psiquiatria, 1991